Portfolio Statistics

Assets

Total Fund AssetsAs of 10/31/2020 (updated monthly) $2,722.7 (M)
Net Assets - Class R As of 10/31/2020 (updated monthly) $1.2 (M)

Positions As of 10/31/2020

Equity VS. MSCI World Value Index-NR

Fund Benchmark
Market CapitalizationAs of 10/31/2020 (updated monthly) $93,653.91(M) $94,804.98(M)
P/B RatioAs of 10/31/2020 (updated monthly) 1.60 1.48
P/E Ratio (12-mo Trailing)As of 10/31/2020 (updated monthly) 17.44 15.91
Price to Cash FlowAs of 10/31/2020 (updated monthly) 8.90 6.50

Portfolio Details

Asset AllocationAs of 10/31/2020

[name] [value]
Equity 95.34%
Cash & Cash Equivalents 2.47%
Fixed Income 2.20%

Geographic BreakdownAs of 10/31/2020

[name] [value]
North America 58.50%
Europe 29.24%
Asia 6.41%
Mid-East/Africa 3.38%
Cash & Cash Equivalents 2.47%
Latin America/Caribbean 0.00%

sector breakdownAs of 10/31/2020

[name] [value]
Pharmaceuticals, Biotechnology & Life Sciences 15.35%
Software & Services 12.35%
Media & Entertainment 10.35%
Technology Hardware & Equipment 8.69%
Food, Beverage & Tobacco 8.46%
Banks 8.30%
Health Care Equipment & Services 6.62%
Consumer Durables & Apparel 5.86%
Capital Goods 5.57%
Telecommunication Services 4.02%
Real Estate 2.99%
Materials 2.48%
Cash & Cash Equivalents 2.47%
Automobiles & Components 2.42%
Insurance 2.30%
Retailing 1.73%
Energy 0.04%
Utilities 0.00%

TOP TEN HOLDINGSAs of 10/31/2020

Issuer Country Industry % of total
CHARTER COMMUNICATIONS INC United States Media & Entertainment 4.53%
GLAXOSMITHKLINE PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 4.30%
ORACLE CORP United States Software & Services 4.11%
SAMSUNG ELECTRONICS CO LTD South Korea Technology Hardware & Equipment 3.95%
SENSATA TECHNOLOGIES HOLDING PLC United States Capital Goods 3.92%
MEDTRONIC PLC United States Health Care Equipment & Services 3.79%
HEINEKEN NV Netherlands Food, Beverage & Tobacco 3.46%
JPMORGAN CHASE & CO United States Banks 3.41%
DEUTSCHE TELEKOM AG Germany Telecommunication Services 3.40%
ELI LILLY AND CO United States Pharmaceuticals, Biotechnology & Life Sciences 3.39%

Market Capitalization BreakdownAs of 10/31/2020

[name] [value]
2.0-5.0 Billion 3.14%
5.0-10.0 Billion 6.91%
10.0-25.0 Billion 15.98%
25.0-50.0 Billion 14.53%
>50.0 Billion 59.45%
N/A 0.00%